Cargando…

Pan‑cancer analysis identified ARHGAP23 as a potential biomarker for pancreatic adenocarcinoma

Rho GTPASE-activating protein 23 (ARHGAP23) is known to activate RHO-GTPase and has an important role in the infiltration and metastasis of tumors. Although previous studies suggested its involvement in certain human cancers, its role in pan-cancer remains unclear. In the present study, the expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaolong, Li, Xin, Wang, Ling, Yu, Kaihua, Wu, Dean, Tao, Pengxian, Li, Yulan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666083/ https://www.ncbi.nlm.nih.gov/pubmed/38022849 http://dx.doi.org/10.3892/mco.2023.2696

Ejemplares similares

ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway
por: Huang, Wen-Kuan, et al.
Publicado: (2021)

ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
por: Yao, Litong, et al.
Publicado: (2023)

ARHGAP25 expression in colorectal cancer as a biomarker associated with favorable prognosis
por: Zhang, Yue, et al.
Publicado: (2022)

Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma
por: Xu, Xiaofeng, et al.
Publicado: (2014)

DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival
por: Hu, Sheng, et al.
Publicado: (2021)

Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers
por: Naeimzadeh, Y., et al.
Publicado: (2023)

Bioinformatics analysis of potential therapeutic targets among ARHGAP genes in breast cancer
por: Chen, Wei-Xian, et al.
Publicado: (2019)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

Pan-cancer analysis of LINC02535 as a potential biomarker and its oncogenic role in lung adenocarcinoma
por: Dai, Shuang, et al.
Publicado: (2022)

PANX1 is a potential prognostic biomarker associated with immune infiltration in pancreatic adenocarcinoma: A pan-cancer analysis
por: Bao, Lingling, et al.
Publicado: (2021)

A Structural Network Analysis of Neuronal ArhGAP21/23 Interactors by Computational Modeling
por: Kouchi, Zen, et al.
Publicado: (2023)

Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer
por: Shen, Qian, et al.
Publicado: (2023)

p190RhoGAPs, the ARHGAP35- and ARHGAP5-Encoded Proteins, in Health and Disease
por: Héraud, Capucine, et al.
Publicado: (2019)

ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Fan, Biao, et al.
Publicado: (2021)

ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway
por: Li, Pengfei, et al.
Publicado: (2020)

The role of ARHGAP9: clinical implication and potential function in acute myeloid leukemia
por: Han, Caixia, et al.
Publicado: (2021)

Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma
por: Xu, Lei, et al.
Publicado: (2022)

An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma
por: de Oliveira, Grasieli, et al.
Publicado: (2020)

An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma
por: Song, Caiyun, et al.
Publicado: (2022)

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
por: Ding, Yongqi, et al.
Publicado: (2023)

Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
por: Li, Yongsheng, et al.
Publicado: (2020)

Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway
por: Zhou, Yongping, et al.
Publicado: (2020)

The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
por: Hsu, Sheng-Kai, et al.
Publicado: (2023)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
por: Liu, Bo, et al.
Publicado: (2021)

miR-939-5p Contributes to the Migration and Invasion of Pancreatic Cancer by Targeting ARHGAP4
por: Shen, Yehua, et al.
Publicado: (2020)

Proteomic analyses identify prognostic biomarkers for pancreatic ductal adenocarcinoma
por: Hu, Dingyuan, et al.
Publicado: (2018)

HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein
por: Li, Yan, et al.
Publicado: (2021)

Aggresome–Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma
por: Zhang, Zhiyong, et al.
Publicado: (2021)

MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma
por: Ding, Feng, et al.
Publicado: (2017)

Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma
por: Cao, Yingying, et al.
Publicado: (2022)

Comprehensive pan-cancer analysis identifies FHL2 associated with poor prognosis in lung adenocarcinoma
por: Pan, Bin, et al.
Publicado: (2023)

Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma
por: Agrawal, Shefali
Publicado: (2017)

Potential biomarkers for early detection of pancreatic ductal adenocarcinoma
por: Kriz, D., et al.
Publicado: (2020)

Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer
por: Yang, Chen, et al.
Publicado: (2021)

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
por: Zhang, Xiaoling, et al.
Publicado: (2023)

Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
por: Zhang, Jing, et al.
Publicado: (2022)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

Bimodal antagonism of PKA signalling by ARHGAP36
por: Eccles, Rebecca L., et al.
Publicado: (2016)

Hematopoietic defects in response to reduced Arhgap21
por: Xavier-Ferrucio, Juliana, et al.
Publicado: (2017)

Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma
por: Zhang, Heng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rt9ua7uidhqg93ivkt8bja0bpq